Epi 1471 - Ibex with Murat Croci
Brian Crombie interviews Murat Croci, co-founder and co-CEO of Ibex Biosciences. They discuss the company's development of a single-dose malaria cure and an antibody drug conjugate targeting chemoresistant colorectal cancer, which has shown 100% efficacy in mouse models.